Similar articles

• Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.

  Hesry V, Piquet-Pellorce C, Travert M, Donaghy L, Jégou B, Patard JJ, Guillaudeux T. Hesry V, et al. Prostate. 2006 Jun 15;66(9):987-95. doi: 10.1002/pros.20421. Prostate. 2006. PMID: 16541419
• Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.

  Izeradjene K, Douglas L, Delaney A, Houghton JA. Izeradjene K, et al. Clin Cancer Res. 2004 Oct 1;10(19):6650-60. doi: 10.1158/1078-0432.CCR-04-0576. Clin Cancer Res. 2004. PMID: 15475455
• FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death.

  Lawrence CP, Chow SC. Lawrence CP, et al. FEBS Lett. 2005 Nov 21;579(28):6465-72. doi: 10.1016/j.febslet.2005.10.041. Epub 2005 Nov 2. FEBS Lett. 2005. PMID: 16289096
• Mechanisms of resistance to TRAIL-induced apoptosis in cancer.

  Zhang L, Fang B. Zhang L, et al. Cancer Gene Ther. 2005 Mar;12(3):228-37. doi: 10.1038/sj.cgt.7700792. Cancer Gene Ther. 2005. PMID: 15550937 Review.
• Targeting death receptors in cancer with Apo2L/TRAIL.

  Kelley SK, Ashkenazi A. Kelley SK, et al. Curr Opin Pharmacol. 2004 Aug;4(4):333-9. doi: 10.1016/j.coph.2004.02.006. Curr Opin Pharmacol. 2004. PMID: 15251125 Review.